MMJ Group Holdings Ltd Stock Market Press Releases and Company Profile
Investor Presentation- MMJ Brands to List on TSX-V via RTO
Investor Presentation- MMJ Brands to List on TSX-V via RTO

Perth, Sep 28, 2016 AEST (ABN Newswire) - MMJ PhytoTech Ltd (googlechartASX:MMJ) is pleased to provide the latest Investor Presentation regarding MMJ Brands to List on TSX-V via RTO.

Executive Summary

MMJ PhytoTech Ltd ('MMJ' or the 'Company') to list Canadia subsidiary United Greeneries ('UG') together with Swiss subsidiary Satipharm ('SAT') on the TSX Venture Exchange ('TSX-V') (the "Transaction")

The new TSX-V listed entity ('TSR') is expected to unlock significant value by providing MMJ shareholders strategic exposure to the rapidly growing Canadian cannabis markets and robust demand for cannabis-focused equities.

Transaction to be completed via $40M Reverse Takeover ('RTO') of TSX-V listed Top Strike Resources (TSX-V:TSR) ('TSR'):

- MMJ to vend UG and SAT into TSR in exchange for $37.5M in TSR equity and $2.5M cash ($40M total consideration).

- TSR to undertake concurrent equity financing of at least $15M ($2.5M of which will be paid to MMJ as partial consideration).

- TSR to undergo 6:1 share consolidation and rebranding forming yet-to-be named Can HoldCo.

Post Transaction, MMJ will have significant ownership in two well-financed, growth-oriented, streamlined cannabis-focused companies:

- ~69% of TSR: TSX-V listed cannabis and cannabis-based products company focused on supplying Canadian and international medical and recreational cannabis markets through two distinct operatin brands:

-- United Greeneries: Canadian Licensed Producer with focus on large scale horticultural operations for the upcoming Canadian recreational cannabis market.

-- Satipharm: International medical cannabis brand with focus on oral delivery technologies for strategic entry in emerging medical cannabis markets and the existing medical cannabis market in Canada.

- 100% of Phytotech Therapeutics ('PTL'): private Israeli pure play biopharmaceutical company focused on developing and commercializing cannabis-based therapeutics by leveraging unique medical cannabis supply chain secured by strategic long-term arrangements between UG, SAT and PTL.

To view the presentation, please visit:
http://abnnewswire.net/lnk/3Z8CVZR7


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/

https://plus.google.com/112611716213432048650/posts https://www.youtube.com/channel/UCkDxKKC_fe2TdZfeVSpPVhw abnnewswire.com 


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 3) (Last 30 Days: 18) (Since Published: 4832)